Analysis-Texas abortion pill ruling could undermine US drug regulator
By Ahmed Aboulenein WASHINGTON (Reuters) – A federal judge’s decision last week to suspend the U.S. Food and Drug Administration’s (FDA) approval of abortion pill mifepristone could severely weaken the agency if allowed to stand, health policy and legal experts said. U.S. District Judge Matthew Kacsmaryk’s ruling on Friday, which followed a March 15 hearing, was a preliminary injunction that would essentially ban sales of mifepristone while the case by […]